Medikabazaar, a leading tech-driven healthcare supply chain Firm has joined hands with Andhra Pradesh Med Tech Zone (AMTZ) to set up an 8,000 sq. ft fulfillment centre within their premises. The centre will cater exclusively to the manufacturing...
Evonik has partnered with specialty chemicals distributor Safic-Alcan to bring nutraceuticals to a broader customer base. The collaboration began on May 1, 2023, and allows Evonik nutraceutical products such as AvailOm, IN VIVO BIOTICS, and...
Delix Therapeutics, a neuroscience company developing novel neuroplasticity-promoting therapeutics for psychiatric and neurological conditions, announced regulatory approval and the start of recruitment for its lead candidate, DLX-001,...
The Board of Directors of Sanofi India Limited today approved the Scheme of Arrangement between SIL and its wholly owned subsidiary Sanofi Consumer Healthcare India Limited (currently in the process of incorporation) ("SCHIL") to demerge SIL's ...
Takeda Biopharmaceuticals, formerly known as Baxalta Bioscience India, has launched its 'Sunrise Patient Services Programme (PSP)' in India for patients with hereditary angioedema (HAE). HAE is a potentially fatal rare genetic disease that affects...
On Tuesday, Mankind Pharma shares debuted on the stock exchange at a 20% premium. The shares closed the day with a 32% rise over the upper end of the IPO price band of Rs 1,080. The stock debuted on the BSE at Rs 1,300 and closed the day...
To commercialise distinctive and ground-breaking products in the areas of Maternal Health & Urology, CORONA Remedies Private Limited (CORONA) has entered into an agreement with Ferring Pharmaceuticals Pvt. Ltd. (Ferring), a subsidiary of global...
Zion Pharma Limited, a Chinese biotechnology firm specialising in the creation of substances that may penetrate the brain, revealed today that Roche has purchased the worldwide rights to Zion's principal programme, ZN-A-1041. ZN-A-1041 is a Human...
Germany's BioNTech, a collaborator with Pfizer on the COVID-19 vaccinations, reported that decreasing demand for the shots contributed to a decline in first-quarter net income as it expanded its work on cancer and other disorders. In order to...
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, announced that it has received a "Day 74" notification from the US Food and Drug Administration (FDA) confirming that the previously submitted New Drug Application....
, CDSCO.jpg)
.jpg)